Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression
Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression
复制标题
DOI：
10.7448/ias.19.1.20636
复制
发表时间：
2016-04-08
影响因子：
6
通讯作者：
Cahn, Pedro
中科院分区：
文献类型：
--
作者：
Rebeiro, Peter F.;Cesar, Carina;Cahn, Pedro
简介：我们评估了艾滋病毒护理连续性结果的趋势与延迟疾病进展和减少在一个大型的拉丁美洲队列中的传播超过十年：临床保留，联合抗逆转录病毒疗法（cART）的使用和病毒抑制（VS）。方法：来自加勒比海，中美洲和南美洲的艾滋病毒流行病学临床队列网络在七个国家的成人贡献了2003年和2012年之间的数据。保留被定义为每年两次或两次以上的艾滋病毒护理访问，间隔>90天。cART定义为每年处方三种或更多种抗逆转录病毒药物。VS定义为HIV-1 RNA
Introduction: We assessed trends in HIV Care Continuum outcomes associated with delayed disease progression and reduced transmission within a large Latin American cohort over a decade: clinical retention, combination antiretroviral therapy (cART) use and viral suppression (VS).Methods: Adults from Caribbean, Central and South America network for HIV epidemiology clinical cohorts in seven countries contributed data between 2003 and 2012. Retention was defined as two or more HIV care visits annually, >90 days apart. cART was defined as prescription of three or more antiretroviral agents annually. VS was defined as HIV-1 RNA